Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II -b, Placebo-Controlled Trial Investigating the Efficacy, Safety and Pharmacokinetics of a Subcutaneous Etonogestrel Implant Combined With i.m. Testosterone Undecanoate for Male Contraception

NCT00403793 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00403793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II -b, Placebo-Controlled Trial Investigating the Efficacy, Safety and Pharmacokinetics of a Subcutaneous Etonogestrel Implant Combined With i.m. Testosterone Undecanoate for Male Contraception
Lead sponsor
Organon and Co
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
December 31, 2006
Enrollment
350 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contraception